Detection of Global DNA Methylation in Cervical Intraepithelial Neoplasia and Cancerous Lesions by Pyrosequencing and Enzyme-Linked Immunosorbent Assays
- PMID: 35092382
- PMCID: PMC9258679
- DOI: 10.31557/APJCP.2022.23.1.143
Detection of Global DNA Methylation in Cervical Intraepithelial Neoplasia and Cancerous Lesions by Pyrosequencing and Enzyme-Linked Immunosorbent Assays
Abstract
Background: Cervical cancer is one of the most significant cancer found in women worldwide especially in developing countries. Previous reports showed that global DNA hypomethylation was correlated with various types of cancer including cervical cancer.
Methods: Long interspersed nuclear element-1 (LINE1) pyrosequencing and Enzyme linked-immunosorbent assay (ELISA) assays were used for detection of global DNA methylation. The ELISA results were compared to bisulfite LINE1 pyrosequencing assay.
Results: Different cervical cancer cell lines (CaSki, SiHa, HeLa, ME180, MS751, C33A) showed low global methylation percentage when compared to normal white blood cells by ELISA assay (1.47%-5.09% vs 8.20%, respectively) and by LINE1 pyrosequencing (20%-45% vs 62%, respectively). Global DNA methylation levels in cervical cancer samples were lower than precancerous lesions (Normal-CIN3) by LINE1 pyrosequencing (mean, 48.8% vs 56.9%, respectively, p<0.05) and ELISA assay (mean, 3.03% vs 3.85%, respectively, p<0.05).
Conclusion: Global DNA hypomethylation was predominantly found in cervical cancer samples detected by ELISA and LINE1 pyrosequencing assays and could be used as triage tests in cervical cancer screening. ELISA assay is a suitable method for detection of global DNA methylation in large population; however, it should be further evaluated in a large clinical samples in order to be used as screening method.
Keywords: Cervical cancer; Long interspersed nuclear element-1 (LINE1); Pyrosequencing; enzyme linked immunosorbent assay; global DNA methylation.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia.BMC Cancer. 2017 Aug 30;17(1):601. doi: 10.1186/s12885-017-3582-0. BMC Cancer. 2017. PMID: 28854904 Free PMC article.
-
Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.Clin Epigenetics. 2020 May 7;12(1):62. doi: 10.1186/s13148-020-00853-1. Clin Epigenetics. 2020. PMID: 32381054 Free PMC article.
-
The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.BJOG. 2021 Feb;128(3):504-514. doi: 10.1111/1471-0528.16395. Epub 2020 Aug 9. BJOG. 2021. PMID: 32619334 Free PMC article. Review.
-
Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.Int J Cancer. 2021 Dec 1;149(11):1916-1925. doi: 10.1002/ijc.33778. Epub 2021 Sep 12. Int J Cancer. 2021. PMID: 34460099
-
Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.Ann Saudi Med. 2016 Sep-Oct;36(5):313-320. doi: 10.5144/0256-4947.2016.313. Ann Saudi Med. 2016. PMID: 27710981 Free PMC article. Review.
Cited by
-
LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples.Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3443-3448. doi: 10.31557/APJCP.2022.23.10.3443. Asian Pac J Cancer Prev. 2022. PMID: 36308370 Free PMC article.
References
-
- Aromseree S, Chaiwongkot A, Ekalaksananan T, et al. The three most cosmmon human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas. J Med Virol. 2014;86:1911–9. - PubMed
-
- Chan PK, Li WH, Chan MY, et al. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol. 1999;59:232–8. - PubMed
-
- Chen CA, Liu CY, Chou HH, et al. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer. 2006;16:1801–8. - PubMed
